App-Quantinova.ai

COMPARATIVE EFFICACY OF METHOTREXATE AND COLCHICINE IN CPPD AND CHRONIC ARTHRITIS PATIENTS

S. Vladimirov - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Osteoporosis

Methotrexate

ANALYSIS OF INTERLEUKIN-1? INHIBITOR (CANAKINUMAB) IMPACT ON ENDOTHELIAL DYSFUNCTION

M. Eliseev - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Vasodilation dysfunction

ILS-969

OXIDATED LIPIDS IN EARLY ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS

N.A. Bashlakova - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

ILS-969

LIVER FAT INDICES RELATE WITH INFLAMMATORY PROFILE IN INFLAMMATORY ARTHRITIS PATIENTS

C. Bruno - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Methotrexate

CIRCULATING SURFACTANT PROTEIN-D (SP-D) MOLECULAR SIZE PROFILE DIFFERS BETWEEN PATIENTS WITH UNTREATED AXIAL SPONDYLOARTHRITIS AND HEALTHY CONTROL SUBJECTS

H.L. Munk - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

Immunol

OSTEOARTHRITIS PAIN IS DIFFERENTIALLY ASSOCIATED WITH TISSUE DEGRADATION AND JOINT INFLAMMATION

A.C. Bay-Jensen - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteoarthritis

N/A

THE PREDICTIVE ROLE OF HIGH SENSITIVE C-REACTIVE PROTEIN AND HIGH DENSITY LIPOPROTEIN IN DEVELOPMENT OF ROTATOR CUFF TEAR IN PATIENTS WITH HAND OSTEOARTHRITIS

H.O. Kim - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Osteoarthritis 2

N/A

COMPARISON OF ANTI-INFLAMMATORY EFFECTS OF THE GEL INCLUDED DICLOFENAC SODIUM AND THE MIXTURE OF ZINGIBER OFFICINALE, HYPERRICUM PERFORATUM, EUGENIA CARYOPHYLLATA AND LAURUS NOBILIS OIL IN COLLAGEN-INDUCED ARTHRITIS MODEL IN RATS

Y. Vural - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Diclofenac Sodium

DOES THE CYTOKINE PATTERN, INCLUDING THE IL23 - IL17 IMMUNE AXIS, CHANGE IN PREGNANT WOMEN WITH PSORIATIC ARTHRITIS?

A. Pluma Sanjurjo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Interleukin

TILDRAKIZUMAB TREATMENT IMPROVED MEASURES OF PSORIATIC ARTHRITIS IN ADULTS WITH CHRONIC PLAQUE PSORIASIS

R.G. Langley - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Tildrakizumab

SERUM INFLAMMATION IDENTIFIES INCREASED RISK OF FRAILTY IN RHEUMATOID ARTHRITIS

J. Andrews - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Prednisone

INCREASED INSULIN RESISTANCE AND IMPAIRED BETA-CELL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: COULD INFLAMMATION FULLY EXPLAIN THESE METABOLIC DISTURBANCES?

G.G. Ristic - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

FATTY LIVER INDEX PREDICTS GLUCOSE METABOLISM DISTURBANCE IN INFLAMMATORY ARTHRITIS PATIENTS

C. Tripolino - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Nonalcoholic fatty liver disease

Oralin

WEAK CORRELATION BETWEEN A MULTI-BIOMARKER DISEASE ACTIVITY SCORE AND CLINICAL RESPONSE WITH BARICITINIB IN A PHASE 2B STUDY IN RHEUMATOID ARTHRITIS

R. Fleischmann - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methotrexate

MORE THAN ONE IN THREE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AT THE ULTRASOUND EXAMINATION OF THEIR HANDS ARE MISCLASSIFIED AS BEING IN REMISSION BY THEIR CLINICIANS: RESULTS FROM A LARGE COHORT STUDY

A. Gill - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

EFFECTS OF IL-6 RECEPTOR INHIBITION THERAPY ON THE SERUM LEVELS OF IL-33 AND IL-6 IN PATIENTS WITH RHEUMATOID ARTHRITIS

I.A. Choi - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Tocilizumab

Analysis of Interleukin-1? Inhibitor (Canakinumab) Impact on Endothelial Dysfunction

M. Eliseev - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Vasodilation dysfunction

ILS-969

Osteoarthritis Pain Is Differentially Associated with Tissue Degradation and Joint Inflammation

A.-C. Bay-Jensen - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Osteoarthritis

N/A

Effects of Infliximab Treatment in Terms of Metabolic Parameters and Insulin Resistance in Ankylosing Spondylitis Patients

A. Cefle - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Ankylosing spondylitis

Infliximab

Serological Markers and Their Correlation with Disease Activity Indexes and Imaging in Patients with Early Axial Spondyloarthritis (Italian Center of Space Study)

M. Lorenzin - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Axial spondyloarthritis

Interleukin

Filters

1408 Abstracts